GLP-1 inhibitors like Wegovy and Mounjaro have revolutionized the weight loss industry, helping people lose weight and putting a major dent in the rising obesity epidemic. But while these drugs can be ...

The telehealth platform was hit earlier this year by the Food & Drug Administration declaring there was no longer a shortage of Ozempic or Wegovy, the GLP-1 drugs sold by Novo Nordisk (NYSE:NVO) for ...

The World Health Organization on Monday recommended GLP-1 drugs as a tool to manage obesity in adults, marking a shift in the way the U.N. agency has historically framed obesity treatment. The WHO ...

GLP-1 weight loss drugs are emerging as a powerful solution for Americans struggling with obesity. Beyond helping people shed pounds, these medications may also improve overall health and extend life ...

As the Food and Drug Administration cracks down on compounded versions of popular weight loss drugs Wegovy (semaglutide) and Zepbound (tirzepatide), Americans who rely on these cheaper medications may ...

A new study hints that pregnant people who have previously taken drugs like Ozempic may face a higher risk of certain poor pregnancy outcomes. But more studies are needed to understand the finding.